Aarhus University Seal

Four large grants from the Novo Nordisk Foundation

DCE has once again received funding from the Novo Nordisk Foundation. Several of these grants are in collaboration with great national and international clinical colleagues.

Fragility fractures, morbidity, and mortality in patients with anorexia nervosa
Medical doctor Sigrid Bjerge Gribsholt has received nearly DKK 2.3 million together with co-applicant associate professor Erzsébet Horváth-Puhó. The grant will fund a PhD position at DCE for a 40-year follow-up study looking at the long-term incidence of fragility fractures, morbidity, and mortality in patients with anorexia nervosa. Sigrid is also affiliated with the Department of Endocrinology and Diabetes at Aarhus University Hospital.


Sub-segmentation in the DD2 cohort
DCE is co-applicant on a 5-year Steno National Collaborative Grant of DKK 25 million. The project "Closing in on sub-segmentation in type 2 diabetes in the Danish nationwide DD2 cohort" is headed by Allan Vaag from Steno Diabetes Center Copenhagen with participants from all five Steno Diabetes Centers. DCE is represented on the project by professor Henrik Toft Sørensen and clinical associate professor Reimar W. Thomsen. Read more about the project here.


Characterization and mitigation of adverse effects of glucocorticoid treatment
DCE is also co-applicant on a 5-year Non-Diabetic Endocrinology National Thematic Collaboration Grant of DKK 25 million. The project “DOUBLE EDGE – Characterization and mitigation of adverse effects of glucocorticoid treatment” is headed by our long-time collaborator professor Jens Otto Lunde Jørgensen at the Department of Endocrinology and Diabetes at Aarhus University Hospital with participants from Odense University Hospital, Rigshospitalet, and the University of Leeds. DCE is represented on the project by professor Henrik Toft Sørensen and postdoc Kristina Laugesen.


Breast cancer and type 2 diabetes
Finally, DCE is co-applicant on a 3-year grant of DKK 6.9 million that will investigate if there is an association between breast cancer and type 2 diabetes. The main applicant is professor Signe Borgquist from the Department of Oncology at Aarhus University Hospital. Associate professor Deirdre Cronin Fenton from DCE is co-applicant, along with professor Jens Meldgaard Bruun (Steno Diabetes Center Aarhus) and professor Jan Frystyk (Odense University Hospital). Clinical associate professor Reimar W. Thomsen will also collaborate from DCE and the project will fund a postdoc and a PhD position at DCE. Read more about the project here (in Danish).